PREDIMED Republished: The Strongest Evidence Yet
In 2018 the landmark PREDIMED trial was retracted over a flaw in how some participants were randomised, then reanalysed and republished — and the headline held: a Mediterranean diet rich in extra-virgin olive oil cut major cardiovascular events by roughly 30 per cent.
PREDIMED is one of the most cited studies in nutrition, and its story is unusually instructive. A large randomised trial of 7,447 people at high cardiovascular risk, it reported that a Mediterranean diet with extra-virgin olive oil (or nuts) cut major cardiovascular events by around 30 per cent versus a low-fat diet. Then, in 2018, it was retracted: reviewers found that some participants had not been randomised properly. The team reanalysed the data, the paper was republished — and the core result stood. That sequence, not just the number, is what makes it worth understanding. This is general information, not medical advice.
What was actually studied
PREDIMED did not test olive oil in a capsule. It compared whole dietary patterns: two versions of a Mediterranean diet — one boosted with extra-virgin olive oil, one with mixed nuts — against a control diet advised to cut fat. The participants were older adults already at high cardiovascular risk, and the trial followed them for years, counting hard outcomes like heart attacks, strokes and cardiovascular deaths. That design — a large, randomised, human trial with real endpoints — sits near the top of the evidence ladder, well above a mouse study or a lab dish.
Why the retraction made it stronger, not weaker
It sounds alarming that a famous trial was retracted. In this case it is reassuring. Reviewers noticed that a subset of participants — about a fifth, some 1,588 of the 7,447 — had been enrolled by household or clinic rather than strictly at random. The authors did not bury it; they reanalysed the data with more conservative methods, and the roughly 30 per cent benefit held. A result that survives its own correction, openly done, is more trustworthy than one that was never checked. Science working as it should is not a scandal.
| Design | Randomised controlled trial (human) |
|---|---|
| Participants | 7,447 adults at high cardiovascular risk |
| Compared | Mediterranean diet + EVOO or nuts vs a low-fat control |
| Main finding | ~30% fewer major cardiovascular events |
| 2018 issue | Some ~1,588 not strictly randomised |
| After reanalysis | Core result held on republication |
| Key nutrients | Monounsaturated fat, polyphenols, whole-diet context |
What it does and doesn’t mean
The honest reading is that it is the whole dietary pattern that helps, with olive oil as its keystone fat — not a magic ingredient taken in isolation. The oil is not a pill; it is the foundation of a way of eating built on vegetables, pulses, fish, nuts and good fat instead of processed food. PREDIMED cannot tell you olive oil alone will protect your heart, and it studied people already at high risk, so it does not translate neatly to everyone. But as evidence that a Mediterranean pattern rich in extra virgin is genuinely good for the heart, it is about as solid as nutrition gets. This is general information, not medical advice.
Practical takeaways
- Think whole pattern, not a single miracle ingredient — olive oil is the keystone fat, not a cure.
- A large randomised human trial outweighs a dozen flashy lab or animal findings.
- A result that survives an open correction is more trustworthy, not less.
- The trial studied high-risk adults; don’t over-extrapolate to everyone.
- For your own health decisions, talk to a clinician — this is general information, not medical advice.
PREDIMED and olive oil: common questions
What did PREDIMED find?
That a Mediterranean diet supplemented with extra-virgin olive oil (or nuts) cut major cardiovascular events by roughly 30 per cent compared with a low-fat control, in people at high cardiovascular risk.
Why was PREDIMED retracted?
Reviewers found that a subset of participants — about a fifth — had not been strictly randomised. The data were reanalysed with more conservative methods and the paper was republished.
Did the retraction change the result?
No. After reanalysis, the roughly 30 per cent benefit held. A result that survives its own open correction is generally more trustworthy, not less.
Does this mean olive oil alone protects your heart?
Not on its own. PREDIMED tested a whole dietary pattern with olive oil as its keystone fat, in high-risk adults — not olive oil taken in isolation. The oil is a foundation, not a pill.
Is this medical advice?
No. This is general information, not medical advice. For decisions about your own diet or heart health, speak to a qualified clinician.
This is the high end of the evidence ladder — a large, randomised, human trial with hard outcomes, not a mouse or a dish — which is exactly why it matters more than a dozen flashy lab findings. And the retraction, far from undermining it, makes it more convincing: the result survived its own open correction. The honest reading is that it’s the whole dietary pattern that helps, with olive oil as its keystone fat. The oil isn’t a pill; it’s the foundation of a way of eating. This is general information, not medical advice.
Drawn from the 2018 retraction and republication of the PREDIMED randomised trial (7,447 participants) and its reanalysed ~30% cardiovascular result.